These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10798555)
1. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary. Sóki J; Urban E; Szöke I; Fodor E; Nagy E J Med Microbiol; 2000 May; 49(5):427-430. PubMed ID: 10798555 [TBL] [Abstract][Full Text] [Related]
2. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?]. Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771 [TBL] [Abstract][Full Text] [Related]
3. High prevalence of division II (cfiA positive) isolates among blood stream Bacteroides fragilis in Slovenia as determined by MALDI-TOF MS. Jeverica S; Sóki J; Premru MM; Nagy E; Papst L Anaerobe; 2019 Aug; 58():30-34. PubMed ID: 30716401 [TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait. Sóki J; Fodor E; Hecht DW; Edwards R; Rotimi VO; Kerekes I; Urbán E; Nagy E J Med Microbiol; 2004 May; 53(Pt 5):413-419. PubMed ID: 15096551 [TBL] [Abstract][Full Text] [Related]
5. A multicentre survey of the antibiotic susceptibility of clinical Bacteroides species from Hungary. Sárvári KP; Sóki J; Kristóf K; Juhász E; Miszti C; Latkóczy K; Melegh SZ; Urbán E Infect Dis (Lond); 2018 May; 50(5):372-380. PubMed ID: 29303023 [TBL] [Abstract][Full Text] [Related]
6. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey. Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE; Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857 [TBL] [Abstract][Full Text] [Related]
7. Prevalence and degree of expression of the carbapenemase gene (cfiA) among clinical isolates of Bacteroides fragilis in Nottingham, UK. Edwards R; Hawkyard CV; Garvey MT; Greenwood D J Antimicrob Chemother; 1999 Feb; 43(2):273-6. PubMed ID: 11252334 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new meropenem-EDTA double-ended Etest strip for the detection of the cfiA metallo-beta-lactamase gene in clinical isolates of Bacteroides fragilis. Bogaerts P; Engelhardt A; Berhin C; Bylund L; Ho P; Yusof A; Glupczynski Y Clin Microbiol Infect; 2008 Oct; 14(10):973-7. PubMed ID: 18828856 [TBL] [Abstract][Full Text] [Related]
9. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary. Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861 [TBL] [Abstract][Full Text] [Related]
10. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene? das Graças Silva E Souza W; Avelar KE; Antunes LC; Lobo LA; Domingues RM; de Souza Ferreira MC J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Carba NP Test for the Detection of Carbapenemase Activity in Bacteroides Species. Akyar I; Ayas M; Karatuna O; Besli Y Pol J Microbiol; 2018 Mar; 67(1):97-101. PubMed ID: 30015430 [TBL] [Abstract][Full Text] [Related]
12. Characterization of a carbapenemase-producing clinical isolate of Bacteroides fragilis in Scandinavia: genetic analysis of a unique insertion sequence. Walsh TR; Onken A; Haldorsen B; Toleman MA; Sundsfjord A Scand J Infect Dis; 2005; 37(9):676-9. PubMed ID: 16126569 [TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan. Ogane K; Tarumoto N; Kodana M; Onodera A; Imai K; Sakai J; Kawamura T; Takeuchi S; Murakami T; Mitsutake K; Ikebuchi K; Maesaki S; Maeda T Anaerobe; 2020 Aug; 64():102215. PubMed ID: 32574601 [TBL] [Abstract][Full Text] [Related]
14. A clinical isolate of Bacteroides fragilis from Hungary with high-level resistance to imipenem. Sóki J; Edwards R; Urbán E; Fodor E; Nagy E J Med Microbiol; 2001 Jan; 50(1):107. PubMed ID: 11192497 [No Abstract] [Full Text] [Related]
15. Distribution of the cfiA gene among Bacteroides fragilis strains in Japan and relatedness of cfiA to imipenem resistance. Yamazoe K; Kato N; Kato H; Tanaka K; Katagiri Y; Watanabe K Antimicrob Agents Chemother; 1999 Nov; 43(11):2808-10. PubMed ID: 10543771 [TBL] [Abstract][Full Text] [Related]
16. Rapid detection and surveillance of cfiA-positive Bacteroides fragilis using matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Kawamoto Y; Kosai K; Ota K; Uno N; Sakamoto K; Hasegawa H; Izumikawa K; Mukae H; Yanagihara K Anaerobe; 2021 Dec; 72():102448. PubMed ID: 34537378 [TBL] [Abstract][Full Text] [Related]
17. Identification of CfiA coding genes in Bacteroides fragilis isolates recovered in Argentina. Inconsistencies in CfiA organization and nomenclature. Litterio MR; Cejas D; Gutkind G; Radice M Anaerobe; 2017 Dec; 48():257-261. PubMed ID: 29017951 [TBL] [Abstract][Full Text] [Related]
18. Emergence of carbapenem resistance in Bacteroides fragilis in China. Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235 [TBL] [Abstract][Full Text] [Related]
19. New insertion sequence elements in the upstream region of cfiA in imipenem-resistant Bacteroides fragilis strains. Kato N; Yamazoe K; Han CG; Ohtsubo E Antimicrob Agents Chemother; 2003 Mar; 47(3):979-85. PubMed ID: 12604530 [TBL] [Abstract][Full Text] [Related]
20. Bacteroides fragilis: A whole MALDI-based workflow from identification to confirmation of carbapenemase production for routine laboratories. Cordovana M; Kostrzewa M; Sóki J; Witt E; Ambretti S; Pranada AB Anaerobe; 2018 Dec; 54():246-253. PubMed ID: 29626622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]